Research Article
Antireflux Metal Stent for Initial Treatment of Malignant Distal Biliary Obstruction
Table 2
Clinical outcomes of the ARMS and c-CSEMS groups.
| | ARMS group () | c-CSEMS group () | value |
| Technical success (%) | 32/32 (100) | 27/27 (100) | — | Functional success (%) | 31/32 (96.9) | 26/27 (96.2) | 1.000 | Median procedure time (min) | 30 (15–50) | 40 (20–70) | 0.735 | Complications (%) | 2 (6.2) | 2 (7.4) | 1.000 | Cholecystitis | 1 | 2 | 0.588 | Liver failure | 1 | 0 | 1.000 | Recurrent biliary obstruction (%) | 15/31 (48.4) | 12/26 (46.2) | 0.866 | Overgrowth | 1 | 1 | 1.000 | Sludge accumulation | 9 | 5 | 0.584 | Food impaction | 0 | 4 | 0.037 | Migration | 5 | 2 | 0.436 | Distal 3 | Distal 2 | Proximal 2 | Proximal 0 | Reintervention (%) | 14/15 (93.3) | 11/12 (91.7) | 1.000 | Cleaning and drainage | 2 | 4 | | Additional stenting (stent in stent) | 0 | 1 | | Replacing stent | 12 | 6 | |
|
|
. ARMS: antireflux metal stent; c-CSEMS: conventional covered self-expandable metal stent. |